SCHEMBL30973284

SCHEMBL30973284

Cc1cc(C)c(-c2cc3scc(C4=CCCN(C)C4)c3nn2)c(O)c1

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
IL1B P01584 1/20 0.37
NLRP3 Q96P20 1/20 0.37
CHRM1 P11229 1/20 0.33
HTR2A P28223 1/20 0.33
CHRM2 P08172 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30973521 0.86 HTR2A (0.36) CHRM1HTR2A
SCHEMBL30973550 0.71 IL1B (0.51) IL1BNLRP3
SCHEMBL30973333 0.70 IL1B (0.43) IL1BNLRP3
SCHEMBL30973530 0.69 HTR2A (0.40) CHRM1HTR2A
SCHEMBL30973453 0.68 CHRM1 (0.33) CHRM1CHRM2CHRM3
SCHEMBL30973594 0.67 CHRM1 (0.35) CHRM1HTR2ACHRM2CHRM3
SCHEMBL30973501 0.62 EED (0.31)
SCHEMBL30993907 0.61 IL1B (0.57) IL1BNLRP3
SCHEMBL9342114 0.58 CHRM2 (0.50) CHRM1CHRM2CHRM3
SCHEMBL22671969 0.56 IL1B (0.78) IL1BNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP claimed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 WO claimed